1.
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
by Wibmer, Constantinos Kurt
Nature medicine, 2021, Vol.27 (4), p.622-625
2.
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
by Xie, Xuping
Nature medicine, 2021, Vol.27 (4), p.620-621
3.
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
by Chen, Rita E
Nature medicine, 2021, Vol.27 (4), p.717-726
4.
5.
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1
by Xu, Kai
Nature medicine, 2018, Vol.24 (6), p.857-867
6.
A multi-laboratory study of diverse RSV neutralization assays indicates feasibility for harmonization with an international standard
by Hosken, Nancy
Vaccine, 2017, Vol.35 (23), p.3082-3088
7.
Comparison of neutralizing antibody titers against outbreak-associated measles genotypes (D4, H1 and B3) in Iran
by Fatemi Nasab, Ghazal Sadat
Pathogens and disease, 2016, Vol.74 (8), p.ftw089
8.
Establishment of the first WHO International Standard for antiserum to Respiratory Syncytial Virus: Report of an international collaborative study
by McDonald, Jacqueline U
Vaccine, 2018, Vol.36 (50), p.7641-7649
9.
10.
Multivariate analysis as a method to evaluate antigenic relationships between BVDV vaccine and field strains
by Mosena, Ana Cristina S
Vaccine, 2020, Vol.38 (36), p.5764-5772
11.
A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infection
by Gautam, Rajeev
Nature medicine, 2018, Vol.24 (5), p.610-616
12.
Potent antibody-mediated neutralization limits bacteriophage treatment of a pulmonary Mycobacterium abscessus infection
by Dedrick, Rebekah M
Nature medicine, 2021, Vol.27 (8), p.1357-1361
13.
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
by Khoury, David S
Nature medicine, 2021, Vol.27 (7), p.1205-1211
14.
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies
by Planas, Delphine
Nature Medicine, 2021, Vol.27 (5), p.917-924
15.
When peaceful people fight: Beyond neutralization and subcultural theory
by Sandberg, Sveinung
British journal of criminology, 2019, Vol.59 (6), p.1309-1327
16.
A serological assay to detect SARS-CoV-2 seroconversion in humans
by Amanat, Fatima
Nature medicine, 2020, Vol.26 (7), p.1033-1036
17.
Fighting Against Corruption: Does Anti-corruption Training Make Any Difference?
by Hauser, Christian
Journal of business ethics, 2018, Vol.159 (1), p.281-299
18.
Characterization of human monoclonal antibodies that neutralize multiple poliovirus serotypes
by Puligedda, Rama Devudu
Vaccine, 2017, Vol.35 (41), p.5455-5462
19.
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals
by Kustin, Talia
Nature medicine, 2021, Vol.27 (8), p.1379-1384
20.
Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351 AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines
by Dubé, Charlotte
Vaccine, 2022, Vol.40 (30), p.4017-4025
